Related Experiment Video
Updated: Jan 19, 2026

Applying X-ray Imaging Crystal Spectroscopy for Use as a High Temperature Plasma Diagnostic
Published on: August 25, 2016
Plasma MicroRNA as a novel diagnostic
Rafal Szelenberger1, Michal Kacprzak2, Joanna Saluk-Bijak1
1Department of General Biochemistry, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland.
MicroRNAs (miRNAs) show promise as non-invasive biomarkers for early disease detection. Their stability and role in gene regulation make them ideal for diagnosing cancer, neurodegenerative, and cardiovascular diseases.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- MicroRNAs (miRNAs) are small, non-coding RNAs regulating gene expression post-transcriptionally.
- Dysregulation of miRNAs is implicated in various diseases, including cancer and neurodegenerative disorders.
- Current diagnostic biomarkers often lack sensitivity, specificity, and non-invasiveness.
Purpose of the Study:
- To review the potential of miRNAs as biomarkers for disease diagnosis.
- To highlight the advantages of miRNAs over traditional biomarkers.
- To explore miRNA applications in oncology, neurology, cardiology, hepatology, and virology.
Main Methods:
- Literature review of studies on miRNA function and disease association.
- Analysis of miRNA stability and presence in biological fluids.
- Examination of experimental findings supporting miRNA biomarker utility.
Main Results:
- miRNAs regulate gene expression by targeting messenger RNAs (mRNAs).
- miRNAs are stable in various biological samples, including blood.
- Emerging evidence supports miRNAs as sensitive and specific biomarkers.
Conclusions:
- miRNAs are valuable candidates for developing novel, non-invasive diagnostic biomarkers.
- Their stability and regulatory roles offer advantages for early disease detection.
- Further research is warranted to translate miRNA biomarker potential into clinical practice.
More Related Videos
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
10:23Absolute Quantification of Plasma MicroRNA Levels in Cynomolgus Monkeys, Using Quantitative Real-time Reverse Transcription PCR
Published on: February 12, 2018
Related Concept Videos
06:46Applying X-ray Imaging Crystal Spectroscopy for Use as a High Temperature Plasma Diagnostic
MicroRNAs
MicroRNAs
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
10:23Absolute Quantification of Plasma MicroRNA Levels in Cynomolgus Monkeys, Using Quantitative Real-time Reverse Transcription PCR
07:37Circulating MicroRNA Quantification Using DNA-binding Dye Chemistry and Droplet Digital PCR